1. WHO . Global Tuberculosis Report 2017. World Health Organization; 2017.
Google Scholar2. Young, F, Wotton, CJ, Critchley, JA, Unwin, NC, Goldacre, MJ. Increased risk of tuberculosis disease in people with diabetes mellitus: record-linkage study in a UK population. J Epidemiol Community Health. 2010;66(6):519-523. doi:10.1136/jech.2010.114595
Google Scholar | Crossref | Medline3. Yorke, E, Atiase, Y, Akpalu, J, Sarfo-Kantanka, O, Boima, V, Dey, ID. The bidirectional relationship between Tuberculosis and diabetes. Tuberc Res Treat. 2017;6:1702578. doi:10.1155/2017/1702578
Google Scholar | Crossref4. Saeedi P,, Petersohn I, Salpea P, et al. Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: Results from the International Diabetes Federation Diabetes Atlas, 9th edition. DRCP. 2019;157(107843):1-10.
Google Scholar5. Niazi, AK, Kalra, S. Diabetes and tuberculosis: a review of the role of optimal glycemic control. J Diabetes Metab Disord. 2012;11(1):2251–6581.
Google Scholar | Crossref6. Stevenson, CR, Critchley, JA, Forouhi, NG, et al. Diabetes and the risk of tuberculosis: a neglected threat to public health? Chronic Illn. 2007;3(3):228–245.
Google Scholar | SAGE Journals7. Pealing, L, Wing, K, Mathur, R, Prieto-Merino, D, Smeeth, L, Moore, DAJ. Risk of tuberculosis in patients with diabetes: population based cohort study using the UK clinical practice research datalink. BMC Med. 2015;13(1):1–16.
Google Scholar | Crossref | Medline8. Noubiap, JJ, Nansseu, JR, Nyaga, UF, et al. Global prevalence of diabetes in active tuberculosis: a systematic review and meta-analysis of data from 2·to 3 million patients with tuberculosis. Lancet Glob Health. 2019;7(4):e448–e460.
Google Scholar | Crossref | Medline9. Alisjahbana, B, Sahiratmadja, E, Nelwan, EJ, et al. The effect of type 2 diabetes mellitus on the presentation and treatment response of pulmonary tuberculosis. Clin Infect Dis. 2007;45(4):428–435.
Google Scholar | Crossref | Medline10. Wilson, RM . Infection and diabetes mellitus. In: Pickup, JC, Williams, G, eds. Textbook of Diabetes. Blackwell Scientific Publication; 1991:813–819.
Google Scholar11. Baker, MA, Harries, AD, Jeon, CY, et al. The impact of diabetes on tuberculosis treatment outcomes: a systematic review. BMC Med. 2011;9(81):1741–7015.
Google Scholar12. Restrepo, BI, Fisher-Hoch, SP, Crespo, JG, et al. Type 2 diabetes and tuberculosis in a dynamic bi-national border population. Epidemiol Infect. 2007;135(3):483–491.
Google Scholar | Crossref | Medline13. Dooley, KE, Tang, T, Golub, JE, Dorman, SE, Cronin, W. Impact of diabetes mellitus on treatment outcomes of patients with active tuberculosis. Am J Trop Med Hyg. 2009;80(4):634–639.
Google Scholar | Crossref | Medline14. Dooley, KE, Chaisson, RE. Tuberculosis and diabetes mellitus: convergence of two epidemics. Lancet Infect Dis. 2009;9(12):737–746.
Google Scholar | Crossref | Medline15. Gautam, S, Shrestha, N, Mahato, S, Nguyen, TP, Mishra, SR, Berg-Beckhoff, G. Diabetes among tuberculosis patients and its impact on tuberculosis treatment in South Asia: a systematic review and meta-analysis. Sci Rep. 2021;11(1):1–12.
Google Scholar | Crossref | Medline16. Kameda, K, Kawabata, S, Masuda, N. Follow-up study of short course chemotherapy for pulmonary tuberculosis complicated with diabetes mellitus. Kekkaku (Tuberculosis). 1990;65(12):791–803.
Google Scholar | Medline17. Singla, R, Khan, N, Al-Sharif, N, Al-Sayegh, MO, Shaikh, MA, Osman, MM. Influence of diabetes on manifestations and treatment outcome of pulmonary TB patients. Int J Tuberc Lung Dis. 2006;10(1):74–79.
Google Scholar | Medline18. Cheng, J, Zhang, H, Zhao, YL, Wang, LX, Chen, MT. Mutual impact of diabetes mellitus and tuberculosis in China. Biomed Environ Sci. 2017;30(5):384–389.
Google Scholar | Medline19. Chiang, CY, Bai, KJ, Lin, HH, et al. The influence of diabetes, glycemic control, and diabetes-related comorbidities on pulmonary tuberculosis. PloS one. 2015;10(3):e0121698
Google Scholar | Crossref20. Morsy, AM, Zaher, HH, Hassan, MH, Shouman, A. Predictors of treatment failure among tuberculosis patients under DOTS strategy in Egypt. East Mediterr Health J. 2003 Jul;9(4):689–701.
Google Scholar | Crossref | Medline21. Jiménez-Corona, ME, Cruz-Hervert, LP, García-García, L, et al. Association of diabetes and tuberculosis: impact on treatment and post-treatment outcomes. Thorax. 2013;68(3):214–220.
Google Scholar | Crossref | Medline22. Singla, R, Osman, M, Khan, N, Al-Sharif, N, Al-Sayegh, M, Shaikh, M. Factors predicting persistent sputum smear positivity among pulmonary tuberculosis patients 2 months after treatment. Int J Tuberc Lung Dis. 2003;7(1):58–64.
Google Scholar | Medline23. Sacks, DB, Bruns, DE, Goldstein, DE, Maclaren, NK, McDonald, JM, Parrott, M. Guidelines and recommendations for laboratory analysis in the diagnosis and management of diabetes mellitus. Clin Chem. 2002;48(3):436–472.
Google Scholar | Crossref | Medline | ISI24. World Health Organization . International Diabetes Federation (2006) Definition and diagnosis of diabetes mellitus and intermediate hyperglycemia: report of a WHO/IDF consultation. IDF Consultation; 2008.
Google Scholar25. Alberti, G, Zimmet, P, Shaw, J, Grundy, SM. The IDF consensus worldwide definition of the metabolic syndrome. Brussels: Int Diabetes Fed. 2006;23(5):469–480.
Google Scholar26. Heysell, SK, Moore, JL, Keller, SJ, Houpt, ER. Therapeutic drug monitoring for slow response to tuberculosis treatment in a state control program, Virginia, USA. Emerg Infect Dis. 2010;16(10):1546.
Google Scholar | Crossref | Medline27. Chang, J-T, Dou, H-Y, Yen, C-L, et al. Effect of type 2 diabetes mellitus on the clinical severity and treatment outcome in patients with pulmonary tuberculosis: a potential role in the emergence of multidrug-resistance. J Formos Med Assoc. 2011;110(6):372–381.
Google Scholar | Crossref | Medline28. Basoglu, OK, Bacakoglu, F, Cok, G, Saymer, A, Ates, M. The oral glucose tolerance test in patients with respiratory infections. Monaldi Arch Chest Dis. 1999;54(4):307–310.
Google Scholar | Medline29. Oluboyo, PO, Erasmus, RT. The significance of glucose intolerance in pulmonary tuberculosis. Tubercle. 1990;71(2):135–138.
Google Scholar | Crossref | Medline30. Geerlings, SE, Hoepelman, AI. Immune dysfunction in patients with diabetes mellitus (DM). FEMS Immunol Med Microbiol. 1999;26(3-4):259–265.
Google Scholar | Crossref | Medline31. Tsukaguchi, K, Yoneda, T, Yoshikawa, M, et al. Case study of interleukin-1 beta, tumor necrosis factor alpha and interleukin-6 production peripheral blood monocytes in patients with diabetes mellitus complicated by pulmonary tuberculosis. Kekkaku. 1992;67(12):755–760.
Google Scholar | Medline32. Moutschen, MP, Scheen, AJ, Lefebvre, PJ. Impaired immune responses in diabetes mellitus: analysis of the factors and mechanisms involved. Relevance to the increased susceptibility of diabetic patients to specific infections. Diabete Metab. 1992;18(3):187–201.
Google Scholar | Medline33. Jeon, CY, Harries, AD, Baker, MA, et al. Bi-directional screening for tuberculosis and diabetes: a systematic review. Research support, Non-US Govt review. Trop Med Int Health. 2010;15(11):1300–1314.
Google Scholar | Crossref | Medline34. Mugusi, F, Swai, AB, Alberti, KG, McLarty, DG. Increased prevalence of diabetes mellitus in patients with pulmonary tuberculosis in Tanzania. Tubercle. 1990;71(4):271–276.
Google Scholar | Crossref | Medline35. Amrit, G, Ashok, S. Tuberculosis and diabetes: an appraisal. Indian J Tuberc. 2000;47(1):3–8.
Google Scholar36. Amare, H, Gelaw, A, Anagaw, B, Gelaw, B. Smear positive pulmonary tuberculosis among diabetic patients at the Dessie referral hospital, northeast Ethiopia. Infect Dis Poverty. 2013;2(1):6.
Google Scholar | Crossref | Medline37. Narasimhan, P, Wood, J, MacIntyre, CR, Mathai, D. Risk factors for tuberculosis. Pulm Med. 2013;2013. doi: 10.1155/2013/828939
Google Scholar | Crossref | Medline38. Kirkman, MS, Briscoe, VJ, Clark, N, et al. Diabetes in older adults. Diabetes Care. 2012;35(12):2650–2664. doi:10.2337/dc12-1801
Google Scholar | Crossref | Medline | ISI39. Schmidt, MI, Duncan, BB, Canani, LH, Karohl, C, Chambless, L. Association of waist-hip ratio with diabetes mellitus: strength and possible modifiers. Diabetes Care. 1992;15(7):912–914.
Google Scholar | Crossref | Medline40. Vazquez, G, Duval, S, Jacobs Jr, DR, Silventoinen, K. Comparison of body mass index, waist circumference, and waist/hip ratio in predicting incident diabetes: a meta-analysis. Epidemiol Rev. 2007;29(1):115–128.
Google Scholar | Crossref | Medline41. Manteuffel, M, Williams, S, Chen, W, Verbrugge, RR, Pittman, DG, Steinkellner, A. Influence of patient sex and gender on medication use, adherence, and prescribing alignment with guidelines. J Womens Health. Feb 2014;23(2):112–119. doi:10.1089/jwh.2012.3972
Google Scholar | Crossref42. Rodriguez Pacheco, R, Negro Alvarez, JM, Campuzano Lopez, FJ, et al. Non-compliance with appointments amongst patients attending an allergology clinic, after implementation of an improvement plan. Allergol Immunopathol (Madr). Jul-Aug 2007;35(4):136–144.
Google Scholar | Crossref | Medline